US Lawyer Database

For Lawyer-Seekers

YOU DESERVE THE BEST LAWYER

Home » US Law » 2022 Nevada Revised Statutes » TITLE 40—PUBLIC HEALTH AND SAFETY » Chapter 457 - Cancer » REGULATION OF DRUGS, MEDICINES, COMPOUNDS OR DEVICES USED IN THE DIAGNOSIS, TREATMENT OR CURE OF CANCER

NRS 457.090 – Statement concerning nature and content of drug, medicine or device to be furnished person before treatment; Division may require statement to be posted in office or room for treatment.

After an investigation by the Division of the content or composition of any drug, medicine, compound or device used by any person or association in the diagnosis, treatment or cure of cancer, the Division shall direct that any such person or association shall, prior to prescribing, recommending or making use of any such drug, medicine, […]

NRS 457.120 – Use of facilities and findings in conducting investigation or test.

In the investigation or testing required by this chapter to determine the value of any drug, medicine, compound or device used in the diagnosis, treatment or cure of cancer, the Division shall, as it deems necessary or advisable, utilize the facilities and findings of its own laboratories or other appropriate laboratories within the State, or […]

NRS 457.130 – Contract for investigation by qualified scientists.

The Division shall arrange by contract for investigation by and submission to it of findings, conclusions or opinions of trained scientists in the appropriate departments of universities and medical schools and other qualified scientists. (Added to NRS by 1960, 64; A 1977, 1222)

NRS 457.150 – Issuance of injunction to restrain violation of cease and desist order.

If any person or association, after service upon the person or association of a cease and desist order issued by the Division under this chapter, persists in prescribing, recommending or using the drug, medicine, compound or device described in the order, any district court, on application of the Division, may issue an injunction or other […]

NRS 457.170 – Publication of report of investigation or test.

The Division may publish reports based on its investigation or testing of any drug, medicine, compound or device prescribed, recommended or used by any person or association, and if the Division determines that the use of any drug, medicine, compound or device in the diagnosis, treatment or cure of cancer constitutes an imminent danger to […]